1. Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli
   Lingbo Kong et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
2. From Crosstalk between Immune and Bone Cells to Bone Erosion in Infection
   Gaurav Kumar et al, 2019, International Journal of Molecular Sciences CrossRef
3. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets
   Hao Zheng et al, 2024, Molecular Medicine CrossRef
4. Inhibition of miR-652-3p Regulates Lipid Metabolism and Inflammatory Cytokine Secretion of Macrophages to Alleviate Atherosclerosis by Improving TP53 Expression
   Haiyun Liu et al, 2022, Mediators of Inflammation CrossRef
5. Koumine inhibits RANKL‐induced ubiquitination and NF‐κB activation to prevent ovariectomy and aging‐induced bone loss
   Jiongming You et al, 2024, Journal of Cellular Biochemistry CrossRef
6. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells
   Chengchao Song et al, 2019, Journal of Cellular Physiology CrossRef
7. Efficacy assessment of methylcellulose-based thermoresponsive hydrogels loaded with gallium acetylacetonate in osteoclastic bone resorption
   Pratyusha Ghanta et al, 2023, Drug Delivery and Translational Research CrossRef
8. Rubiadin-1-methyl ether from Morinda officinalis How. Inhibits osteoclastogenesis through blocking RANKL-induced NF-κB pathway
   Yu-Qiong He et al, 2018, Biochemical and Biophysical Research Communications CrossRef